265 related articles for article (PubMed ID: 17397297)
81. Studying multiple protein profiles over time to assess biomarker validity.
Kasthuri RS; Verneris MR; Ibrahim HN; Jilma B; Nelsestuen GL
Expert Rev Proteomics; 2006 Aug; 3(4):455-64. PubMed ID: 16901203
[TBL] [Abstract][Full Text] [Related]
82. [Establishment of protein fingerprint database of Salmonella paratyphi A using SELDI-TOF-MS].
Li XQ; Huang WF; Liu H; Yang YC; Xiao DW; Yan H; Luo CL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jun; 28(6):576-9. PubMed ID: 22691346
[TBL] [Abstract][Full Text] [Related]
83. Peak selection from MALDI-TOF mass spectra using ant colony optimization.
Ressom HW; Varghese RS; Drake SK; Hortin GL; Abdel-Hamid M; Loffredo CA; Goldman R
Bioinformatics; 2007 Mar; 23(5):619-26. PubMed ID: 17237065
[TBL] [Abstract][Full Text] [Related]
84. Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices.
Poon TC
Expert Rev Proteomics; 2007 Feb; 4(1):51-65. PubMed ID: 17288515
[TBL] [Abstract][Full Text] [Related]
85. Surface enhanced laser desorption ionization spectrometry reveals biomarkers for drug treatment but not dose.
Paweletz CP; Wiener MC; Sachs JR; Meurer R; Wu MS; Wong KK; Yates NA; Hendrickson RC
Proteomics; 2006 Apr; 6(7):2101-7. PubMed ID: 16518871
[TBL] [Abstract][Full Text] [Related]
86. Annotated regions of significance of SELDI-TOF-MS spectra for detecting protein biomarkers.
Tan CS; Ploner A; Quandt A; Lehtiö J; Pernemalm M; Lewensohn R; Pawitan Y
Proteomics; 2006 Dec; 6(23):6124-33. PubMed ID: 17072907
[TBL] [Abstract][Full Text] [Related]
87. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study.
Streckfus CF; Bigler LR; Zwick M
J Oral Pathol Med; 2006 May; 35(5):292-300. PubMed ID: 16630293
[TBL] [Abstract][Full Text] [Related]
88. Mass spectrometric profiling - a diagnostic tool in fish?
Provan F; Bjørnstad A; Pampanin DM; Lyng E; Fontanillas R; Andersen OK; Koppe W; Bamber S
Mar Environ Res; 2006 Jul; 62 Suppl():S105-8. PubMed ID: 16764920
[TBL] [Abstract][Full Text] [Related]
89. Biomarker discovery from body fluids using mass spectrometry.
Villar-Garea A; Griese M; Imhof A
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):105-14. PubMed ID: 17097359
[TBL] [Abstract][Full Text] [Related]
90. A serum proteomics approach to the diagnosis of ectopic pregnancy.
Gerton GL; Fan XJ; Chittams J; Sammel M; Hummel A; Strauss JF; Barnhart K
Ann N Y Acad Sci; 2004 Jun; 1022():306-16. PubMed ID: 15251976
[TBL] [Abstract][Full Text] [Related]
91. Enrichment of low-molecular-weight proteins from biofluids for biomarker discovery.
Chertov O; Simpson JT; Biragyn A; Conrads TP; Veenstra TD; Fisher RJ
Expert Rev Proteomics; 2005 Jan; 2(1):139-45. PubMed ID: 15966859
[TBL] [Abstract][Full Text] [Related]
92. Diagnostic values of surface-enhanced laser desorption/ionization technology for screening of habitual drinkers.
Sogawa K; Itoga S; Tomonaga T; Nomura F
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S22-6. PubMed ID: 17331162
[TBL] [Abstract][Full Text] [Related]
93. Prediction of renal allograft rejection by urinary protein analysis using ProteinChip Arrays (surface-enhanced laser desorption/ionization time-of-flight mass spectrometry).
Reichelt O; Müller J; von Eggeling F; Driesch D; Wunderlich H; Schubert J; Gröne HJ; Stein G; Ott U; Junker K
Urology; 2006 Mar; 67(3):472-5. PubMed ID: 16527560
[TBL] [Abstract][Full Text] [Related]
94. Characterization of canine mitochondrial protein expression in natural and induced forms of idiopathic dilated cardiomyopathy.
Lopes R; Solter PF; Sisson DD; Oyama MA; Prosek R
Am J Vet Res; 2006 Jun; 67(6):963-70. PubMed ID: 16740088
[TBL] [Abstract][Full Text] [Related]
95. A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis.
Stone JH; Rajapakse VN; Hoffman GS; Specks U; Merkel PA; Spiera RF; Davis JC; St Clair EW; McCune J; Ross S; Hitt BA; Veenstra TD; Conrads TP; Liotta LA; Petricoin EF;
Arthritis Rheum; 2005 Mar; 52(3):902-10. PubMed ID: 15751091
[TBL] [Abstract][Full Text] [Related]
96. Peptide and protein profiles in serum and follicular fluid of women undergoing IVF.
Schweigert FJ; Gericke B; Wolfram W; Kaisers U; Dudenhausen JW
Hum Reprod; 2006 Nov; 21(11):2960-8. PubMed ID: 16893915
[TBL] [Abstract][Full Text] [Related]
97. Is SELDI-TOF a valid tool for diagnostic biomarkers?
Ndao M; Rainczuk A; Rioux MC; Spithill TW; Ward BJ
Trends Parasitol; 2010 Dec; 26(12):561-7. PubMed ID: 20708969
[TBL] [Abstract][Full Text] [Related]
98. Finding regions of significance in SELDI measurements for identifying protein biomarkers.
Tan CS; Ploner A; Quandt A; Lehtiö J; Pawitan Y
Bioinformatics; 2006 Jun; 22(12):1515-23. PubMed ID: 16567365
[TBL] [Abstract][Full Text] [Related]
99. [Discovery of biomarkers in the serum from patients with hypertensive disorder complicating pregnancy].
Lü YJ; Li L; Yu LL; Xu Y
Zhonghua Fu Chan Ke Za Zhi; 2005 May; 40(5):306-8. PubMed ID: 15938778
[TBL] [Abstract][Full Text] [Related]
100. Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometry.
He J; Gornbein J; Shen D; Lu M; Rovai LE; Shau H; Katz J; Whitelegge JP; Faull KF; Chang HR
Int J Oncol; 2007 Jan; 30(1):145-54. PubMed ID: 17143523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
